Home
About
Overview
Sharing Data
ORCID
Help
History (1)
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 01; 48(1):187-194.
View in:
PubMed
subject areas
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Animals
Brain Neoplasms
Disease Models, Animal
Female
Hemangioma, Cavernous, Central Nervous System
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Mice
Mice, Transgenic
Protein Kinase Inhibitors
rho-Associated Kinases
Simvastatin
authors with profiles
Romuald Girard
Robert Shenkar
Issam Awad
James Liao
Peter Pytel